NYSE:GUG Guggenheim Active Allocation Fund (GUG) Stock Price, News & Analysis $15.85 -0.03 (-0.21%) As of 02:00 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsDividendHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Guggenheim Active Allocation Fund Stock (NYSE:GUG) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get GUG alerts:Sign Up Key Stats Today's Range$15.77▼$15.8950-Day Range$14.87▼$16.0452-Week Range$14.70▼$16.50Volume49,767 shsAverage Volume74,141 shsMarket CapitalizationN/AP/E RatioN/ADividend Yield8.96%Price TargetN/AConsensus RatingN/A Company Overview Guggenheim Active Allocation Fund is a diversified, closed-end management investment company trading on the New York Stock Exchange under the ticker symbol GUG. The fund aims to provide a combination of current income and capital appreciation by employing an actively managed, multi-asset strategy. Its investment universe spans global equity securities, fixed-income instruments, convertible securities and derivative instruments, allowing the portfolio to capture opportunities across market cycles and geographic regions. Employing a dynamic asset allocation framework, the fund’s management team adjusts exposures based on market valuations, economic outlooks and risk assessments. The strategy may incorporate equity index futures, interest rate swaps, options and other derivatives to fine-tune sector and duration weights, hedge currency risks or seek incremental returns. This flexibility is designed to help the fund adapt to changing market environments and pursue attractive risk-adjusted returns. Guggenheim Active Allocation Fund is advised by Guggenheim Funds Investment Advisors, LLC, an indirect subsidiary of Guggenheim Partners, a global investment and advisory firm serving a broad range of institutional and individual clients. Oversight is provided by an independent board of directors, which focuses on governance, regulatory compliance and alignment of the fund’s objectives with shareholder interests.AI Generated. May Contain Errors. Read More Receive GUG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Guggenheim Active Allocation Fund and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GUG Stock News HeadlinesGuggenheim Active Allocation Fund (NYSE:GUG) Trading Down 0.1% - Should You Sell?May 5, 2026 | americanbankingnews.comGuggenheim Investments Announces April 2026 Closed-End Fund DistributionsApril 1, 2026 | markets.businessinsider.comRead this or regret it foreverThree Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change.May 12 at 1:00 AM | Porter & Company (Ad)Guggenheim Investments Announces March 2026 Closed-End Fund DistributionsMarch 2, 2026 | globenewswire.comGuggenheim Limited Duration Fund Q4 2025 CommentaryFebruary 12, 2026 | seekingalpha.comGUG: Cautious About Dividend Coverage But Still An Attractive BuyJanuary 29, 2026 | seekingalpha.comGuggenheim Maintains Alphabet (GOOGL) Buy RecommendationDecember 1, 2025 | msn.comGuggenheim Investments Announces December 2025 Closed-End Fund DistributionsDecember 1, 2025 | globenewswire.comSee More Headlines GUG Stock Analysis - Frequently Asked Questions How have GUG shares performed this year? Guggenheim Active Allocation Fund's stock was trading at $15.28 at the beginning of the year. Since then, GUG stock has increased by 3.7% and is now trading at $15.8450. When did Guggenheim Active Allocation Fund IPO? Guggenheim Active Allocation Fund (GUG) raised $0 in an initial public offering on Wednesday, November 24th 2021. The company issued 0 shares at a price of $0.00 per share. Who are Guggenheim Active Allocation Fund's major shareholders? Guggenheim Active Allocation Fund's top institutional investors include Ascentis Independent Advisors and World Investment Advisors. Insiders that own company stock include Ronald E Toupin Jr, Angela Brock-Kyle and Ronald Nyberg. View institutional ownership trends. How do I buy shares of Guggenheim Active Allocation Fund? Shares of GUG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Guggenheim Active Allocation Fund own? Based on aggregate information from My MarketBeat watchlists, some other companies that Guggenheim Active Allocation Fund investors own include British American Tobacco (BTI), Calamos Convertible and High Income Fund (CHY), Gabelli Equity Trust (GAB), Altria Group (MO), PIMCO High Income Fund (PHK), Verizon Communications (VZ) and AGNC Investment (AGNC). Company Calendar Record date for 4/30 Dividend4/15/2026Ex-Dividend for 4/30 Dividend4/15/2026Dividend Payable4/30/2026Today5/12/2026Record date for 5/29 Dividend5/15/2026Ex-Dividend for 5/29 Dividend5/15/2026Dividend Payable5/29/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 GUG's financial health is in the Green zone, according to TradeSmith. GUG has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNYSE SectorN/A Industry - Sub-IndustryN/A Current SymbolNYSE:GUG CIK1864208 WebN/A Phone312-827-0100FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$42.79 million Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableN/A BetaN/A 7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NYSE:GUG) was last updated on 5/12/2026 by MarketBeat.com Staff. From Our PartnersNNVC FDA = New Momentum Wave!NanoViricides (NYSE: NNVC) just received FDA Orphan Drug Designation for NV-387, its antiviral candidate targe...Equiscreen | SponsoredRise of the… petroyuan?On February 28th, Iran installed a yuan-denominated toll at the Strait of Hormuz - the chokepoint for one in e...Golden Portfolio | SponsoredBSEM: From OTC to Nasdaq Contender!BioStem Technologies (OTC: BSEM) has posted seven consecutive profitable quarters and just released audited fi...Huge Alerts | SponsoredRead this or regret it foreverThree Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...Porter & Company | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredIf You Have $50k+ on Coinbase, This Will Ruin Your DayIn 2009, Greece's debt-to-GDP ratio hit 130%. Within 24 months... Pensions were slashed 40% overnight. Bank ac...Decentralized Masters | SponsoredSpaceX Launches Strange 'Dark Energy' Across AmericaSpaceX is deploying a newly permitted energy technology - one that analyst Joel Litman calls 'Dark Energy' - t...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guggenheim Active Allocation Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share Guggenheim Active Allocation Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GUG Stock Alerts